SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

77,264.51 330.92
( 0.43%)

Global Indices

Nasdaq

53,583.69 98.81
(0.18%)

Dow Jones

7,750.97 54.27
(0.71%)

Hang Seng

66,369.62 237.64
(0.36%)

Nikkei 225

10,795.58 -82.54
(-0.76%)

Forex

USD-INR

95.26 -0.05
(-0.05%)

EUR-INR

111.07 -0.11
(-0.10%)

GBP-INR

129.70 -0.28
(-0.21%)

JPY-INR

0.60 0.00
(0.01%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Nath Bio-Genes (India) Ltd

Industry : Miscellaneous

BSE Code

ISIN Demat

Book Value()

537291

INE448G01010

362.7520522

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

NATHBIOGEN

6.67

290.38

EPS(TTM)

Face Value()

Div & Yield %

22.92

1.31

Back

R R Financial Consultants consolidated net profit rises 23.20% in the June 2026 quarter

Aug 10,2026

Net profit of R R Financial Consultants rose 23.20% to Rs 3.08 crore in the quarter ended June 2026 as against Rs 2.50 crore during the previous quarter ended June 2025. Sales declined 16.59% to Rs 8.85 crore in the quarter ended June 2026 as against Rs 10.61 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	8.85	10.61	-17
OPM %	43.62	34.31	-
PBDT	3.96	3.50	13
PBT	3.92	3.45	14
NP	3.08	2.50	23

77,264.51 330.92 ( 0.43%)

53,583.69 98.81 (0.18%)

7,750.97 54.27 (0.71%)

66,369.62 237.64 (0.36%)

10,795.58 -82.54 (-0.76%)

95.26 -0.05 (-0.05%)

111.07 -0.11 (-0.10%)

129.70 -0.28 (-0.21%)

0.60 0.00 (0.01%)